What Has Driven the Growth of the Biopharmaceuticals Contract Manufacturing Market in Recent Years?
The biopharmaceuticals contract manufacturing market has seen considerable growth due to a variety of factors.
•The growth in the biopharmaceuticals contract manufacturing market has been swift in recent years, surging from $20.13 billion in 2024 to a projected $22.21 billion in 2025. This growth signifies a compound annual growth rate (CAGR) of 10.3%.
The expansion during this historical period can be credited to factors such as enhanced biopharmaceutical development, more cost-efficient and risk-reducing measures, an expanding pipeline of biologics, the internationalization of the biopharmaceutical industry, and adaptable manufacturing solutions.
What is the Market Size Forecast for the Biopharmaceuticals Contract Manufacturing Market?
The biopharmaceuticals contract manufacturing market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the market size for contract manufacturing in the biopharmaceuticals sector is anticipated to experience a significant upsurge. It is projected to escalate to "$33.75 billion by 2029 with a compound annual growth rate (CAGR) of 11.0%.
Factors such as burgeoning outsourcing trends, advancement in biosimilar development, decreased time-to-market demands, international market proliferation, and emphasis on specialized services are the key contributors to this projected growth. The forecast period will witness trends like technological integration, expansion of outsourcing beyond large molecules, adoption of cutting-edge manufacturing technologies, intensified focus on quality and regulatory compliance, and the emergence of biosimilars production.
Which Factors Are Boosting Growth In The Biopharmaceuticals Contract Manufacturing Market?
The surge in the need for personalized medicine is predicted to drive the expansion of the biopharmaceutical contract manufacturing market in the future. Personalized medicine is a tailor-made healthcare strategy considering individual patient traits, like genetics, environment, and lifestyle to boost the success and results of the treatment. The escalating need for personalized medicine is triggered by several elements, such as improvements in genomics, patient empowerment, and heightened efficiency of treatments. Contract manufacturers can formulate customized manufacturing processes to meet the specific needs of personalized treatments, allowing for smaller batch sizes and distinct formulations. For example, the Personalized Medicine Coalition, a non-profit organization based in the US, reported in February 2024 that the FDA had authorized 16 new personalized treatments for patients suffering from rare diseases in 2023, a considerable increase from six in 2022. Consequently, the escalating need for personalized medicine stimulates the expansion of the biopharmaceutical contract manufacturing market.
What Key Areas Define The Segmentation Of The Global Biopharmaceuticals Contract Manufacturing Market?
The biopharmaceuticals contract manufacturing market covered in this report is segmented –
1) By Product: Biologics, Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAi, And Molecular Therapy, Biosimilars
2) By Source: Mammalian, Non-mammalian
3) By Service: Process Development, Fill And Finish Operations, Analytical And QC studies, Packaging
4) By Application: Clinical, Commercial
Subsegments:
1) By Biologics: Enzymes, Hormones, Antibodies
2) By Monoclonal Antibodies (MABs): Human MABs, Chimeric MABs, Murine MABs
3) By Recombinant Proteins: Insulin, Growth Factors, Cytokines
4) By Vaccines: Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines
5) By Antisense, RNAi, And Molecular Therapy: Antisense Oligonucleotides, RNA Interference Products, Gene Therapies
6) By Biosimilars: Biosimilar Monoclonal Antibodies, Biosimilar Insulin, Biosimilar Growth Hormones
Pre-Book The Biopharmaceuticals Contract Manufacturing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
How Are Emerging Trends Reshaping The Dynamics Of The Biopharmaceuticals Contract Manufacturing Market?
One major trend emerging in the biopharmaceuticals contract manufacturing market is the emphasis on product innovation. Dominant businesses in this sector are creating innovative items to maintain their market relevance. For instance, in February 2023, Thermo Fisher Scientific, a noted American biotechnology research firm, alongside Elektrofi, a US firm specializing in advancing drug formulation and delivery, entered into a strategic contract manufacturing partnership. This was aimed at supporting the commercial production of groundbreaking ultra-high concentration subcutaneous products from Elektrofi. Leveraging its proprietary microparticle technology, Elektrofi enables small-volume injections of important biologics such as monoclonal antibodies, therapeutic proteins, and other critical large-molecule medications. Furthermore, Elektrofi's platform technology empowers patients to self-medicate at home, thereby overcoming the challenges often faced with administering biologic-based medications in hospital environments.
Who Are the Key Players in the Biopharmaceuticals Contract Manufacturing Market?
Major companies operating in the biopharmaceuticals contract manufacturing market include:
• Boehringer Ingelheim GmbH
• Lonza Group Ltd.
• Inno Biologics Sdn Bhd
• Rentschler Biopharma SE
• Samsung Biologics Co. Ltd.
• AGC Biologics
• ProBioGen AG
• FUJIFILM Diosynth Biotechnologies
• Thermo Fisher Scientific Inc.
• Binex Co. Ltd.
• AbbVie Inc.
• Catalent Inc
• Pfizer Inc.
• Merck KGaA
• Pressure BioSciences
• Novartis International AG
• Cambrex Corporation
• Emergent BioSolutions Inc.
• JRS Pharma GmbH & Co. KG
• WuXi Biologics
• Siegfried Holding AG
• Toyobo Co. Ltd.
• ADMA Biologics Inc.
• UCB S.A.
• AstraZeneca PLC
• Johnson & Johnson
• Takeda Pharmaceutical Company Limited
• Shire Pharmaceuticals LLC
• Baxter International Inc.
• Becton Dickinson and Company
• Polyphor Ltd.
• Patheon Inc.
• Alcami Corporation
What Is The Most Dominant Region In The Biopharmaceuticals Contract Manufacturing Market?
North America was the largest region in the biopharmaceutical contract manufacturing market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global biopharmaceuticals contract manufacturing market forecast period. The regions covered in the biopharmaceuticals contract manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
